Forte Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Forte Biosciences

08/11/2021 22:01

* Forte Biosciences Inc  FBRX.OQ  reported a quarterly adjusted
loss of 54 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 36 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Forte Biosciences Inc's reported EPS for the quarter was a
loss of 54 cents​.
* The mean earnings estimate of analysts had risen by about 11%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Forte Biosciences Inc shares had risen by 8.8% this
quarter and lost 91.2% so far this year.
* The company reported a quarterly loss of $7.75 million.
* Wall Street's median 12-month price target for Forte
Biosciences Inc is $3.25 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated